首页 | 本学科首页   官方微博 | 高级检索  
检索        


Tumor-derived IL-6 and trans-signaling among tumor,fat, and muscle mediate pancreatic cancer cachexia
Authors:Joseph E Rupert  Ashok Narasimhan  Daenique HA Jengelley  Yanlin Jiang  Jianguo Liu  Ernie Au  Libbie M Silverman  George Sandusky  Andrea Bonetto  Sha Cao  Xiaoyu Lu  Thomas M O&#x;Connell  Yunlong Liu  Leonidas G Koniaris  Teresa A Zimmers
Abstract:Most patients with pancreatic adenocarcinoma (PDAC) suffer cachexia; some do not. To model heterogeneity, we used patient-derived orthotopic xenografts. These phenocopied donor weight loss. Furthermore, muscle wasting correlated with mortality and murine IL-6, and human IL-6 associated with the greatest murine cachexia. In cell culture and mice, PDAC cells elicited adipocyte IL-6 expression and IL-6 plus IL-6 receptor (IL6R) in myocytes and blood. PDAC induced adipocyte lipolysis and muscle steatosis, dysmetabolism, and wasting. Depletion of IL-6 from malignant cells halved adipose wasting and abolished myosteatosis, dysmetabolism, and atrophy. In culture, adipocyte lipolysis required soluble (s)IL6R, while IL-6, sIL6R, or palmitate induced myotube atrophy. PDAC cells activated adipocytes to induce myotube wasting and activated myotubes to induce adipocyte lipolysis. Thus, PDAC cachexia results from tissue crosstalk via a feed-forward, IL-6 trans-signaling loop. Malignant cells signal via IL-6 to muscle and fat, muscle to fat via sIL6R, and fat to muscle via lipids and IL-6, all targetable mechanisms for treatment of cachexia.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号